Clinical trial

Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

NCT01548482

Study summary

ClinicalTrials.gov

Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

OTHER · Unmapped registry intervention Laboratory Biomarker Analysis Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Pharmacological Study Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Temsirolimus Normalized identity: temsirolimus View linked drug · Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention Trebananib Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-03-01

PhasePHASE1

Conditions

Adult Solid Neoplasmunresolved

Lung Carcinoid Tumorverified · MONDO: lung carcinoid tumor

Recurrent Digestive System Neuroendocrine Tumor G1unresolved

Recurrent Renal Cell Carcinomaunresolved

Recurrent Uterine Corpus Sarcomaunresolved

Stage III Renal Cell Cancerunresolved

Stage IIIB Uterine Sarcomaunresolved

Stage IIIC Uterine Sarcomaunresolved

Stage IV Renal Cell Cancerunresolved

Stage IVA Uterine Sarcomaunresolved

Stage IVB Uterine Sarcomaunresolved

Interventions

Laboratory Biomarker AnalysisOTHER

Pharmacological StudyOTHER

TemsirolimusDRUG · verified · RxNorm: temsirolimus

TrebananibBIOLOGICAL

Sponsors & collaborators

National Cancer Institute (NCI)lead sponsor

Mapped research locations

TorontoOntario, Canada1 VancouverBritish Columbia, Canada1 HamiltonOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01548482 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.